Northfield Capital Corporation Acquires Securities of Canada Lithium Corp.

Northfield Capital Corporation Acquires Securities of Canada Lithium Corp. 
TORONTO, ONTARIO -- (Marketwired) -- 05/17/13 -- Northfield Capital
Corporation ("Northfield") (TSX VENTURE:NFD.A) of 141 Adelaide Street
West, Suite 301, Toronto, Ontario announces that it has acquired
ownership and control of an aggregate of 7,000 convertible debentures
(the "Debentures") of Canada Lithium Corp. (the "Company") at a cost
of $1,000 per Debenture, through a private placement on May 15, 2013,
representing approximately 2.6% of the issued and outstanding common
shares of the Company as at May 15, 2013 on a partially diluted
basis, assuming the conversion of the principal amount of the
Debentures only.  
Upon completion of the transaction described above, Northfield owns
and controls an aggregate of 24,335,000 common shares of the Company
(the "Owned Shares") and convertible securities entitling Northfield
to acquire an additional 11,097,222 common shares of the Company (the
"Convertible Securities") as well as the right to acquire certain
additional common shares of the Company issuable in connection with
certain interest payments owing under the Debentures, to be
calculated at the time of the issuance of such additional common
shares (the "Interest Shares"). The Owned Shares represent
approximately 6.7% of the issued and outstanding common shares of the
Company as of May 15, 2013. The Owned Shares together with the common
shares issuable pursuant to the Convertible Securities represent
approximately 9.5% of the issued and outstanding common shares of the
Company as of May 15, 2013, calculated on a partially diluted basis,
assuming the issuance of the 11,097,222 common shares issuable upon
exercise or conversion of the Convertible Securities only.  
Upon completion of the transaction described above, Northfield,
together with its joint actor Mr. Robert Cudney, own and control an
aggregate of 24,986,000 common shares of the Company (the "Owned
Joint Actor Shares") (of which 24,335,000 common shares are owned by
Northfield directly and 651,000 common shares are owned by its joint
actor), and convertible securities entitling Northfield and its joint
actor to acquire an additional 12,797,222 common shares of the
Company (the "Joint Actor Convertible Securities"), as well as the
right to acquire the Interest Shares (of which 11,097,222 common
shares issuable pursuant to the Joint Actor Convertible Securities
and the right to acquire the Interest Shares are owned by Northfield
directly and 1,700,000 common shares issuable pursuant to the Joint
Actor Convertible Securities are owned by its joint actor). The Owned
Joint Actor Shares represent approximately 6.9% of the issued and
outstanding common shares of the Company as of May 15, 2013. The
Owned Joint Actor Shares together with the common shares issuable
pursuant to the Joint Actor Convertible Securities represent
approximately 10.1% of the issued and outstanding common shares of
the Company as of May 15, 2013, calculated on a partially diluted
basis, assuming the issuance of the 12,797,222 common shares issuable
upon exercise or conversion of the Joint Actor Convertible Securities
only.  
The Debentures were acquired in a private placement transaction which
did not take place through the facilities of any market for the
Company's securities. This transaction was effected for investment
purposes and Northfield and its joint actor, Mr. Cudney, could
increase or decrease their investments in the Company at any time, or
continue to maintain their current investment position, depending on
market conditions or any other relevant factor. The Debentures were
acquired for a purchase price of Cdn$1,000 per Debenture for
aggregate consideration of $7,000,000, pursuant to the exemption
contained in Section 2.3 of National Instrument 45-106 on the basis
that Northfield is an accredited investor as defined in such
instrument. 
Additional Information  
A copy of the applicable securities report filed in connection with
the matters set forth above may be obtained through Northfield's
offices by contacting:  


 
Brent Peters                                                                
Northfield Capital Corporation                                              
141 Adelaide Street West, Suite 301                                         
Toronto, ON M5H 3L5                                                         
                                                                            
Tel: (416) 628-5901                                                         
Fax: (416) 628-5911                                                         

 
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER
(AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE)
ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. 
Contacts:
Northfield Capital Corporation
Brent Peters
(416) 628-5901
(416) 628-5911 (FAX)
 
 
Press spacebar to pause and continue. Press esc to stop.